Diabetes Board decisions

The Veteran's initial disability rating for diabetic nephropathy was reduced from 80% to 60%, effective October 15, 2019. The claim for a higher initial rating remains denied.

The Board has granted service connection for peripheral neuropathy affecting both lower extremities, a vestibular disorder, and diabetes mellitus, Type II. The Veteran's claim for service connection for diabetes mellitus, Type II is remanded.

The Veteran's Diabetes Mellitus, Type II is related to service due to herbicide exposure and significantly contributed to his death. The Board granted the claim for service connection for the cause of the Veteran's death.

The Board has remanded the case due to insufficient evidence regarding herbicide exposure in Okinawa, Japan. The Veteran claims his diabetes is related to this exposure.

The Veteran's claims for service connection have been reopened and are granted.,The Veteran is entitled to service connection for his acquired psychiatric disorder, bilateral hearing loss, skin condition, lung and/or breathing condition, left knee injury, right knee injury, cardiovascular problems (formerly claimed as heart problems), and diabetes mellitus type II.

The Veteran's claim for a rating in excess of 20 percent for diabetes mellitus from October 2, 2013 is denied. The Veteran's claim for TDIU is granted.

The Board has denied service connection for peripheral neuropathy of the right and left lower extremities, as well as left ulnar neuropathy, diabetes mellitus, vascular disorders of the lower extremities, and special monthly pension based on need for regular aid and attendance or housebound status. The claims are remanded for additional development.

The Board has remanded the Veteran's claims for diabetic foot disease and neck disability due to incomplete development of records and inadequate opinion regarding service connection.

The Board has determined that additional development is necessary for the claims of service connection for type II diabetes mellitus, left lower extremity peripheral neuropathy, sleep apnea, and erectile dysfunction. The case is being remanded to allow for further examination and opinion.

The Veteran's death was due to liver failure, but the cause of his service-connected conditions is unclear. The Board finds that remand is necessary as the VA medical opinion did not adequately address the role of diabetes and other service-connected conditions in causing the Veteran's death.

The Veteran's diabetes is granted as service connected due to exposure to herbicide agents during his active duty in Korea, and the presumption of service connection applies.

The Board has remanded the cases for further development regarding potential exposure to herbicide agents during service in Panama. The Veteran's claims for various conditions are now pending.

The Board has remanded the Veteran's increased rating claim for diabetes mellitus type II and his service connection claim for foot arthritis and leg arthritis, to include as secondary to service-connected diabetes mellitus type II. The Veteran is required to be provided with a VA examination to assess the current severity of his diabetes mellitus and an additional opinion on whether his foot arthritis and leg arthritis are caused by or have been aggravated by his service-connected diabetes mellitus.

The Veteran's claims for effective dates prior to December 29, 2015 and September 11, 2017 for the grant of service connection for CAD and diabetes mellitus II have been denied.,The Veteran's claims for initial ratings in excess of 10 percent for CAD and diabetes mellitus II are remanded. The Veteran's claim for TDIU is also remanded.

The Board has granted service connection for chronic B cell leukemia and diabetes mellitus type II, finding that the Veteran was exposed to herbicide agents during his active duty service in Vietnam. The decision is based on credible testimony regarding exposure and proximity to the border.

The Veteran's diabetes mellitus, type II, is granted as service-connected due to exposure to Agent Orange during his service in Thailand.

The Veteran's heart disease and diabetes mellitus type II are granted as service connected due to presumed exposure to Agent Orange during his military service in Vietnam.

The Veteran is granted a TDIU from January 26, 2021, through July 28, 2021. From July 29, 2021, the appeal for a TDIU is dismissed as moot due to his current combined rating of 100%.

The Veteran's claims for service connection for various nerve disorders and diabetes mellitus have been denied. The Board has found that the Veteran did not meet the criteria for service connection due to lack of evidence linking his conditions to his active military service, with some issues remanded for further examination.

The Veteran's claims for service connection for residuals to a left eye injury, diabetes mellitus, type II, ischemic heart disease (IHD) (diagnosed as stroke), bilateral hearing loss, and left knee patellofemoral pain syndrome have all been denied. The Board found no current disabilities related to the claimed conditions.